Ravi Kalhan1,2, Mark T Dransfield3, Laura A Colangelo2, Michael J Cuttica1, David R Jacobs4, Bharat Thyagarajan5, Raul San Jose Estepar6, Rola Harmouche6, Jorge Onieva Onieva6, Samuel Y Ash6,7, Yuka Okajima6, Carlos Iribarren8, Stephen Sidney8, Cora E Lewis9, David M Mannino10, Kiang Liu2, Lewis J Smith1,2, George R Washko6,7. 1. 1 Division of Pulmonary and Critical Care Medicine and. 2. 2 Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois. 3. 3 Division of Pulmonary, Allergy, and Critical Care Medicine and. 4. 4 Division of Epidemiology and Community Health, University of Minnesota School of Public Health, Minneapolis, Minnesota. 5. 5 Department of Pathology and Laboratory Medicine, University of Minnesota School of Medicine, Minneapolis, Minnesota. 6. 6 Applied Chest Imaging Laboratory, Department of Radiology, and. 7. 7 Division of Research, Kaiser Permanente of Northern California, Oakland, California; and. 8. 8 Division of Preventive Medicine, University of Alabama-Birmingham, Birmingham, Alabama. 9. 9 Department of Preventive Medicine and Environmental Health, University of Kentucky College of Public Health, Lexington, Kentucky. 10. 10 Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Abstract
RATIONALE: There are limited data on factors in young adulthood that predict future lung disease. OBJECTIVES: To determine the relationship between respiratory symptoms, loss of lung health, and incident respiratory disease in a population-based study of young adults. METHODS: We examined prospective data from 2,749 participants in the CARDIA (Coronary Artery Risk Development in Young Adults) study who completed respiratory symptom questionnaires at baseline and 2 years later and repeated spirometry measurements over 30 years. MEASUREMENTS AND MAIN RESULTS: Cough or phlegm, episodes of bronchitis, wheeze, shortness of breath, and chest illnesses at both baseline and Year 2 were the main predictor variables in models assessing decline in FEV1 and FVC from Year 5 to Year 30, incident obstructive and restrictive lung physiology, and visual emphysema on thoracic computed tomography scan. After adjustment for covariates, including body mass index, asthma, and smoking, report of any symptom was associated with -2.71 ml/yr excess decline in FEV1 (P < 0.001) and -2.18 in FVC (P < 0.001) as well as greater odds of incident (prebronchodilator) obstructive (odds ratio [OR], 1.63; 95% confidence interval [CI], 1.24-2.14) and restrictive (OR, 1.40; 95% CI, 1.09-1.80) physiology. Cough-related symptoms (OR, 1.56; 95% CI, 1.13-2.16) were associated with greater odds of future emphysema. CONCLUSIONS: Persistent respiratory symptoms in young adults are associated with accelerated decline in lung function, incident obstructive and restrictive physiology, and greater odds of future radiographic emphysema.
RATIONALE: There are limited data on factors in young adulthood that predict future lung disease. OBJECTIVES: To determine the relationship between respiratory symptoms, loss of lung health, and incident respiratory disease in a population-based study of young adults. METHODS: We examined prospective data from 2,749 participants in the CARDIA (Coronary Artery Risk Development in Young Adults) study who completed respiratory symptom questionnaires at baseline and 2 years later and repeated spirometry measurements over 30 years. MEASUREMENTS AND MAIN RESULTS: Cough or phlegm, episodes of bronchitis, wheeze, shortness of breath, and chest illnesses at both baseline and Year 2 were the main predictor variables in models assessing decline in FEV1 and FVC from Year 5 to Year 30, incident obstructive and restrictive lung physiology, and visual emphysema on thoracic computed tomography scan. After adjustment for covariates, including body mass index, asthma, and smoking, report of any symptom was associated with -2.71 ml/yr excess decline in FEV1 (P < 0.001) and -2.18 in FVC (P < 0.001) as well as greater odds of incident (prebronchodilator) obstructive (odds ratio [OR], 1.63; 95% confidence interval [CI], 1.24-2.14) and restrictive (OR, 1.40; 95% CI, 1.09-1.80) physiology. Cough-related symptoms (OR, 1.56; 95% CI, 1.13-2.16) were associated with greater odds of future emphysema. CONCLUSIONS: Persistent respiratory symptoms in young adults are associated with accelerated decline in lung function, incident obstructive and restrictive physiology, and greater odds of future radiographic emphysema.
Authors: Isabel Urrutia; Alberto Capelastegui; José María Quintana; Nerea Muñiozguren; Xavier Basagana; Jordi Sunyer Journal: Eur J Public Health Date: 2005-04 Impact factor: 3.367
Authors: Emily S Wan; John E Hokanson; James R Murphy; Elizabeth A Regan; Barry J Make; David A Lynch; James D Crapo; Edwin K Silverman Journal: Am J Respir Crit Care Med Date: 2011-04-14 Impact factor: 21.405
Authors: George R Washko; David A Lynch; Shin Matsuoka; James C Ross; Shigeaki Umeoka; Alejandro Diaz; Frank C Sciurba; Gary M Hunninghake; Raúl San José Estépar; Edwin K Silverman; Ivan O Rosas; Hiroto Hatabu Journal: Acad Radiol Date: 2009-09-24 Impact factor: 3.173
Authors: James P Allinson; Rebecca Hardy; Gavin C Donaldson; Seif O Shaheen; Diana Kuh; Jadwiga A Wedzicha Journal: Am J Respir Crit Care Med Date: 2016-03-15 Impact factor: 21.405
Authors: Yannick Molgat-Seon; Paolo B Dominelli; Carli M Peters; Jordan A Guenette; A William Sheel; Igor M Gladstone; Andrew T Lovering; Joseph W Duke Journal: Am J Physiol Regul Integr Comp Physiol Date: 2019-08-21 Impact factor: 3.619
Authors: Wassim W Labaki; Lucas M Kimmig; Gökhan M Mutlu; MeiLan K Han; Surya P Bhatt Journal: Am J Respir Crit Care Med Date: 2019-06-15 Impact factor: 21.405
Authors: Yunus Çolak; Shoaib Afzal; Børge G Nordestgaard; Jørgen Vestbo; Peter Lange Journal: Am J Respir Crit Care Med Date: 2020-03-15 Impact factor: 21.405
Authors: Paul A Reyfman; George R Washko; Mark T Dransfield; Avrum Spira; MeiLan K Han; Ravi Kalhan Journal: Am J Respir Crit Care Med Date: 2018-08-15 Impact factor: 21.405
Authors: J Michael Wells; Laura A Colangelo; Lakshmi Sivarajan; Bharat Thyagarajan; Mark T Dransfield; Carlos Iribarren; Paul A Reyfman; David R Jacobs; George R Washko; Ravi Kalhan Journal: Eur Respir J Date: 2019-01-17 Impact factor: 16.671
Authors: Sneha Thatipelli; Kiarri N Kershaw; Laura A Colangelo; Penny Gordon-Larsen; David R Jacobs; Mark T Dransfield; Daniel Meza; Sharon R Rosenberg; George R Washko; Trisha M Parekh; Mercedes R Carnethon; Ravi Kalhan Journal: Am J Med Date: 2021-09-09 Impact factor: 4.965
Authors: Paul A Reyfman; Elizabeth Sugar; Heather Hazucha; Jenny Hixon; Curt Reynolds; Sonali Bose; Mark T Dransfield; MeiLan K Han; Raul San Jose Estepar; Mary B Rice; George R Washko; Mercedes Carnethon; Ravi Kalhan Journal: BMJ Open Date: 2021-07-05 Impact factor: 3.006